Mexico - North America Alzheimers Disease Diagnostics Market Size & Outlook

Name: Mexico - North America Alzheimers Disease Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The alzheimers disease diagnostics market in Mexico - North America is expected to reach a projected revenue of US$ 334.0 million by 2033. A compound annual growth rate of 10.7% is expected of Mexico - North America alzheimers disease diagnostics market from 2026 to 2033.

Clinical Diagnostics
- In Vitro Diagnostics
  - Alzheimers Disease Diagnostics Market Outlook

Mexico alzheimers disease diagnostics diagnostic technique outlook (Revenue, USD million, 2021-2033)
- Biomarkers
  - CSF Biomarkers
  - Blood-based Biomarkers
- Imaging Techniques
- Genetic Testing
- Cognitive Assessment Tests
Mexico alzheimers disease diagnostics type outlook (Revenue, USD million, 2021-2033)
- Triage
- Diagnosis
- Screening
Mexico alzheimers disease diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes

Mexico - North America Alzheimers Disease Diagnostics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!